Expert Interview
Looking at Medtronic's BrainSense Adaptive deep brain stimulation (DBS) device, recently approved by the FDA for the treatment of Parkinson's Disease
Ticker(s): MDTInstitution: University of Miami
- Assistant Professor of Clinical Neurology in the Movement Disorders Division at the University of Miami.
- Currently manages 80 patients with Alzheimer's disease.
- Research interests include Parkinson' disease and a broad interest in neurodegenerative disorders and movement disorders in particular.
Describe your background and practice setting
Looking ahead, how do you envision DBS role evolving in the landscape of Parkinson's disease treatment?
Added By: ben_adminRank your excitement for the BrainSense Adaptive DBS device on a scale of 1-10
Added By: ben_adminWhich patients will be candidates for DBS devices?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
